355 related articles for article (PubMed ID: 22575581)
1. Docosahexaenoic acid homeostasis, brain aging and Alzheimer's disease: Can we reconcile the evidence?
Cunnane SC; Chouinard-Watkins R; Castellano CA; Barberger-Gateau P
Prostaglandins Leukot Essent Fatty Acids; 2013 Jan; 88(1):61-70. PubMed ID: 22575581
[TBL] [Abstract][Full Text] [Related]
2. Unresolved issues in the link between docosahexaenoic acid and Alzheimer's disease.
Plourde M; Fortier M; Vandal M; Tremblay-Mercier J; Freemantle E; Bégin M; Pifferi F; Cunnane SC
Prostaglandins Leukot Essent Fatty Acids; 2007; 77(5-6):301-8. PubMed ID: 18036804
[TBL] [Abstract][Full Text] [Related]
3. Ageing and apoE change DHA homeostasis: relevance to age-related cognitive decline.
Hennebelle M; Plourde M; Chouinard-Watkins R; Castellano CA; Barberger-Gateau P; Cunnane SC
Proc Nutr Soc; 2014 Feb; 73(1):80-6. PubMed ID: 24103099
[TBL] [Abstract][Full Text] [Related]
4. Fish, docosahexaenoic acid and Alzheimer's disease.
Cunnane SC; Plourde M; Pifferi F; Bégin M; Féart C; Barberger-Gateau P
Prog Lipid Res; 2009 Sep; 48(5):239-56. PubMed ID: 19362576
[TBL] [Abstract][Full Text] [Related]
5. The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer's disease.
Belkouch M; Hachem M; Elgot A; Lo Van A; Picq M; Guichardant M; Lagarde M; Bernoud-Hubac N
J Nutr Biochem; 2016 Dec; 38():1-11. PubMed ID: 27825512
[TBL] [Abstract][Full Text] [Related]
6. Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2.
Vandal M; Alata W; Tremblay C; Rioux-Perreault C; Salem N; Calon F; Plourde M
J Neurochem; 2014 May; 129(3):516-26. PubMed ID: 24345162
[TBL] [Abstract][Full Text] [Related]
7. Docosahexaenoic acid supplementation of primary rat hippocampal neurons attenuates the neurotoxicity induced by aggregated amyloid beta protein(42) and up-regulates cytoskeletal protein expression.
Wang PY; Chen JJ; Su HM
J Nutr Biochem; 2010 Apr; 21(4):345-50. PubMed ID: 19423322
[TBL] [Abstract][Full Text] [Related]
8. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
[TBL] [Abstract][Full Text] [Related]
9. Towards a nutritional approach for prevention of Alzheimer's disease: biochemical and cellular aspects.
Florent-Béchard S; Malaplate-Armand C; Koziel V; Kriem B; Olivier JL; Pillot T; Oster T
J Neurol Sci; 2007 Nov; 262(1-2):27-36. PubMed ID: 17681547
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance.
Su HM
J Nutr Biochem; 2010 May; 21(5):364-73. PubMed ID: 20233652
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Docosahexaenoic Acid on Alzheimer's Disease: Is There a Role of the Blood-Brain Barrier?
Pan Y; Khalil H; Nicolazzo JA
Curr Clin Pharmacol; 2015; 10(3):222-41. PubMed ID: 26338174
[TBL] [Abstract][Full Text] [Related]
12. Disturbance in uniformly 13C-labelled DHA metabolism in elderly human subjects carrying the apoE ε4 allele.
Chouinard-Watkins R; Rioux-Perreault C; Fortier M; Tremblay-Mercier J; Zhang Y; Lawrence P; Vohl MC; Perron P; Lorrain D; Brenna JT; Cunnane SC; Plourde M
Br J Nutr; 2013 Nov; 110(10):1751-9. PubMed ID: 23631810
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies.
Calon F; Cole G
Prostaglandins Leukot Essent Fatty Acids; 2007; 77(5-6):287-93. PubMed ID: 18037281
[TBL] [Abstract][Full Text] [Related]
14. Fatty acid facts, Part IV: docosahexaenoic acid and Alzheimer's disease. A story of mice, men and fish.
Pauwels EK; Volterrani D; Mariani G; Kairemo K
Drug News Perspect; 2009 May; 22(4):205-13. PubMed ID: 19536365
[TBL] [Abstract][Full Text] [Related]
15. ω-3 fatty acids in the prevention of cognitive decline in humans.
Cederholm T; Salem N; Palmblad J
Adv Nutr; 2013 Nov; 4(6):672-6. PubMed ID: 24228198
[TBL] [Abstract][Full Text] [Related]
16. Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer's disease mouse model.
Cole GM; Frautschy SA
Nutr Health; 2006; 18(3):249-59. PubMed ID: 17180870
[TBL] [Abstract][Full Text] [Related]
17. Omega-3 fatty acids in neurodegenerative diseases: focus on mitochondria.
Eckert GP; Lipka U; Muller WE
Prostaglandins Leukot Essent Fatty Acids; 2013 Jan; 88(1):105-14. PubMed ID: 22727983
[TBL] [Abstract][Full Text] [Related]
18. Inadequate supply of vitamins and DHA in the elderly: implications for brain aging and Alzheimer-type dementia.
Mohajeri MH; Troesch B; Weber P
Nutrition; 2015 Feb; 31(2):261-75. PubMed ID: 25592004
[TBL] [Abstract][Full Text] [Related]
19. Carriers of an apolipoprotein E epsilon 4 allele are more vulnerable to a dietary deficiency in omega-3 fatty acids and cognitive decline.
Nock TG; Chouinard-Watkins R; Plourde M
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Oct; 1862(10 Pt A):1068-1078. PubMed ID: 28733268
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers of DHA status.
Kuratko CN; Salem N
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):111-8. PubMed ID: 19545987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
